ClinicalTrials.Veeva

Menu

Fertility After Intrauterine Tamponing Balloon: Where Are we (FERTIBTIU)

U

University Hospital, Lille

Status

Completed

Conditions

Fertility Disorders
Hemorrhage Postpartum

Study type

Observational

Funder types

Other

Identifiers

NCT04133402
2017_89
2018-A01609-46 (Other Identifier)

Details and patient eligibility

About

Today, few data are available on the patient's fertility following intrauterine tamponade balloon (BTIU) used for postpartum hemorrhage (PPH) after vaginal delivery (AVB). Several studies have concluded that there are no fertility disorders after conservative surgical treatment or embolization. BTIU is an essential treatment in the management of PPH. The aim was to evaluate post-BTIU fertility and the appearance of gynecological symptoms.

This is a bicentric retrospective study (Valenciennes, Lille, France), between 2012 and 2017. The data will be collected by telephone interview on fertility and various gynecological functional symptoms.

Enrollment

59 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Vaginal birth
  • Post partum haemorrhage
  • Intrauterine tamponing balloon
  • Between 2012 and 2017
  • CHRU Lille and CH Valenciennes

Exclusion criteria

  • Minor patients
  • Initial intake started in another center (postpartum transfer).
  • Refusal to participate in the study
  • Invasive treatments for postpartum haemorrhage
  • Caesarean

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems